tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
TipRanksTop Financial ExpertsInsidersKaren Zaderej

Karen Zaderej Insider Profile

4 Followers
Karen Zaderej, CEO, Director at AxoGen, holds 38.50K shares in EyePoint Pharmaceuticals (Ticker: EYPT), holds 1.14M shares in AxoGen (Ticker: AXGN), holds 62.35K shares in Viveve Medical (Ticker: VIVE).
See the Hottest Stocks Based on Insider Trading >
tipranks
Karen Zaderej

Karen Zaderej
AxoGen (AXGN)
CEO, Director

Ranked #1,993 out of 103,606 Corporate Insiders

Profitable Transactions

91%
10 out of 11 Profitable Transactions

Average Return

+51.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$20M
97.35%
2.65%
0.00%
A breakdown of Karen Zaderej's holdings
See the Top Stocks by Insiders

Insider Roles

AxoGen
(AXGN)
CEO, Director
EyePoint Pharmaceuticals
(EYPT)
Director
Viveve Medical
(VIVE)
Director
Roles that Karen Zaderej holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
EyePoint Pharmaceuticals
(EYPT)
Rating:Informative Buy
Date:May 15, 2025 - Today
Return:+131.60%
The most profitable trade made by Karen Zaderej
See the Latest Stocks Traded by Insiders

Karen Zaderej's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AXGN
AxoGen
Mar 25, 2024
CEO, Director
Uninformative Buy
545.60K
$19.63M
VIVE
Viveve Medical
Jul 02, 2019
Director
Uninformative Buy
―
―
EYPT
EyePoint Pharmaceuticals
Jul 11, 2025
Director
Uninformative Buy
22.12K
$535.15K
List of latest transactions for each holding click on a transaction to see Karen Zaderej's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Karen Zaderej insider profile FAQ

What is the percentage of profitable transactions made by Karen Zaderej?
The percentage of profitable transactions made by Karen Zaderej is 91%.
    What is the average return per transaction made by Karen Zaderej?
    The average return per transaction made by Karen Zaderej is 51.80%.
      What stocks does Karen Zaderej hold?
      Karen Zaderej holds: AXGN, VIVE, EYPT stocks.
        What was Karen Zaderej’s latest transaction?
        Karen Zaderej latest transaction was an Uninformative Buy of $22.12K.
          What was Karen Zaderej's most profitable transaction?
          Karen Zaderej’s most profitable transaction was an Informative Buy of EYPT stock on May 15, 2025. The return on the trade was 131.60%.
            What is Karen Zaderej's role in AxoGen?
            Karen Zaderej's role in AxoGen is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.